What is LL-37?

LL-37 is a human antimicrobial peptide belonging to the cathelicidin family. It plays a crucial role in the innate immune system by providing a first line of defense against microbial infections. Found in various body fluids and tissues, LL-37 is not only known for its antimicrobial properties but also for its ability to modulate immune responses and promote tissue repair and regeneration.

Mechanism of Action

LL-37 functions by integrating into and disrupting the membranes of bacteria, viruses, and fungi, leading to their destruction. Beyond its direct antimicrobial activity, LL-37 is involved in modulating the immune system. It influences the activity of immune cells such as neutrophils, macrophages, and T-cells, enhancing their ability to respond to infections. Additionally, LL-37 is known to promote the migration and proliferation of cells necessary for tissue repair, thereby aiding in wound healing processes.

Clinical Applications

LL-37 has shown potential in various clinical applications, particularly in regenerative medicine. It is used to enhance wound healing, especially in chronic and non-healing wounds like diabetic ulcers. Its ability to modulate immune responses also makes it a candidate for treating inflammatory conditions and infections where traditional antibiotics might fail. Research is ongoing to explore its full potential in regenerative therapies.

Safety & Side Effects

LL-37 is generally considered safe, but like any therapeutic agent, it can have side effects. The most common side effect reported is local irritation at the site of application. Systemic side effects are rare due to its localized application in most therapeutic settings. Ongoing studies are evaluating its long-term safety profile, especially in chronic treatments. It is important for patients to consult with their healthcare provider to ensure its appropriateness for their specific condition.